Patients' experiences and views of cascade screening for familial hypercholesterolemia (FH): a qualitative study

Nina Hallowell, Nick Jenkins, Margaret Douglas, Simon Walker, Robert Finnie, Mary Porteous, Julia Lawton

Research output: Contribution to journalArticle

Abstract

Familial DNA cascade screening for familial hypercholesterolemia (FH) has recently been introduced in Scotland. This study investigated index patients' experiences of DNA testing and mediating cascade screening. Thirty-eight patients with a clinical diagnosis of definite or possible FH who had undergone DNA testing in the lipid clinic took part in semi-structured qualitative interviews. All patients were positive about DNA screening being undertaken by familiar and trusted clinicians within the lipid clinic. Most patients had already cascaded close relatives for serum cholesterol testing following their attendance at the lipid clinic. Identified mutation carriers who had attended the genetics clinic (n = 15) for a cascading appointment described finding this consultation helpful because it identified other at-risk family members and provided them with tailored information for their relatives. Participants who expressed a preference said they favoured indirect (patient-mediated) methods of cascading as they considered indirect approaches to be less threatening to family members than direct clinical contact. We conclude that DNA screening and indirect familial cascading is perceived as highly acceptable to index patients with FH. However, while indirect cascading methods may be more acceptable to patients, they do not yield the same numbers as more direct methods. There is, therefore, a need for further systematic research to investigate patients', family members' and staff views of the acceptability of direct versus indirect methods of cascade screening.

Original languageEnglish
Pages (from-to)249-257
Number of pages9
JournalJournal of Community Genetics
Volume2
Issue number4
DOIs
Publication statusPublished - Dec 2011
Externally publishedYes

Fingerprint

Hyperlipoproteinemia Type II
DNA
Lipids
Scotland
Appointments and Schedules
Referral and Consultation
Cholesterol
Interviews
Mutation
Serum
Research

Keywords

  • Familial hypercholesterolemia (FH)
  • Indirect cascade screening
  • Qualitative interviews

Cite this

Hallowell, Nina ; Jenkins, Nick ; Douglas, Margaret ; Walker, Simon ; Finnie, Robert ; Porteous, Mary ; Lawton, Julia. / Patients' experiences and views of cascade screening for familial hypercholesterolemia (FH) : a qualitative study. In: Journal of Community Genetics. 2011 ; Vol. 2, No. 4. pp. 249-257.
@article{e4c0b520e68642baadc4eb4ef5e0c9dd,
title = "Patients' experiences and views of cascade screening for familial hypercholesterolemia (FH): a qualitative study",
abstract = "Familial DNA cascade screening for familial hypercholesterolemia (FH) has recently been introduced in Scotland. This study investigated index patients' experiences of DNA testing and mediating cascade screening. Thirty-eight patients with a clinical diagnosis of definite or possible FH who had undergone DNA testing in the lipid clinic took part in semi-structured qualitative interviews. All patients were positive about DNA screening being undertaken by familiar and trusted clinicians within the lipid clinic. Most patients had already cascaded close relatives for serum cholesterol testing following their attendance at the lipid clinic. Identified mutation carriers who had attended the genetics clinic (n = 15) for a cascading appointment described finding this consultation helpful because it identified other at-risk family members and provided them with tailored information for their relatives. Participants who expressed a preference said they favoured indirect (patient-mediated) methods of cascading as they considered indirect approaches to be less threatening to family members than direct clinical contact. We conclude that DNA screening and indirect familial cascading is perceived as highly acceptable to index patients with FH. However, while indirect cascading methods may be more acceptable to patients, they do not yield the same numbers as more direct methods. There is, therefore, a need for further systematic research to investigate patients', family members' and staff views of the acceptability of direct versus indirect methods of cascade screening.",
keywords = "Familial hypercholesterolemia (FH), Indirect cascade screening, Qualitative interviews",
author = "Nina Hallowell and Nick Jenkins and Margaret Douglas and Simon Walker and Robert Finnie and Mary Porteous and Julia Lawton",
year = "2011",
month = "12",
doi = "10.1007/s12687-011-0064-y",
language = "English",
volume = "2",
pages = "249--257",
journal = "Journal of Community Genetics",
issn = "1868-310X",
publisher = "Springer-Verlag",
number = "4",

}

Patients' experiences and views of cascade screening for familial hypercholesterolemia (FH) : a qualitative study. / Hallowell, Nina; Jenkins, Nick; Douglas, Margaret; Walker, Simon; Finnie, Robert; Porteous, Mary; Lawton, Julia.

In: Journal of Community Genetics, Vol. 2, No. 4, 12.2011, p. 249-257.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Patients' experiences and views of cascade screening for familial hypercholesterolemia (FH)

T2 - a qualitative study

AU - Hallowell, Nina

AU - Jenkins, Nick

AU - Douglas, Margaret

AU - Walker, Simon

AU - Finnie, Robert

AU - Porteous, Mary

AU - Lawton, Julia

PY - 2011/12

Y1 - 2011/12

N2 - Familial DNA cascade screening for familial hypercholesterolemia (FH) has recently been introduced in Scotland. This study investigated index patients' experiences of DNA testing and mediating cascade screening. Thirty-eight patients with a clinical diagnosis of definite or possible FH who had undergone DNA testing in the lipid clinic took part in semi-structured qualitative interviews. All patients were positive about DNA screening being undertaken by familiar and trusted clinicians within the lipid clinic. Most patients had already cascaded close relatives for serum cholesterol testing following their attendance at the lipid clinic. Identified mutation carriers who had attended the genetics clinic (n = 15) for a cascading appointment described finding this consultation helpful because it identified other at-risk family members and provided them with tailored information for their relatives. Participants who expressed a preference said they favoured indirect (patient-mediated) methods of cascading as they considered indirect approaches to be less threatening to family members than direct clinical contact. We conclude that DNA screening and indirect familial cascading is perceived as highly acceptable to index patients with FH. However, while indirect cascading methods may be more acceptable to patients, they do not yield the same numbers as more direct methods. There is, therefore, a need for further systematic research to investigate patients', family members' and staff views of the acceptability of direct versus indirect methods of cascade screening.

AB - Familial DNA cascade screening for familial hypercholesterolemia (FH) has recently been introduced in Scotland. This study investigated index patients' experiences of DNA testing and mediating cascade screening. Thirty-eight patients with a clinical diagnosis of definite or possible FH who had undergone DNA testing in the lipid clinic took part in semi-structured qualitative interviews. All patients were positive about DNA screening being undertaken by familiar and trusted clinicians within the lipid clinic. Most patients had already cascaded close relatives for serum cholesterol testing following their attendance at the lipid clinic. Identified mutation carriers who had attended the genetics clinic (n = 15) for a cascading appointment described finding this consultation helpful because it identified other at-risk family members and provided them with tailored information for their relatives. Participants who expressed a preference said they favoured indirect (patient-mediated) methods of cascading as they considered indirect approaches to be less threatening to family members than direct clinical contact. We conclude that DNA screening and indirect familial cascading is perceived as highly acceptable to index patients with FH. However, while indirect cascading methods may be more acceptable to patients, they do not yield the same numbers as more direct methods. There is, therefore, a need for further systematic research to investigate patients', family members' and staff views of the acceptability of direct versus indirect methods of cascade screening.

KW - Familial hypercholesterolemia (FH)

KW - Indirect cascade screening

KW - Qualitative interviews

U2 - 10.1007/s12687-011-0064-y

DO - 10.1007/s12687-011-0064-y

M3 - Article

VL - 2

SP - 249

EP - 257

JO - Journal of Community Genetics

JF - Journal of Community Genetics

SN - 1868-310X

IS - 4

ER -